Skye Bioscience, Inc. (SKYE) Net income 2016–2025
Skye Bioscience, Inc. (SKYE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$55.9MFY2025 · since FY2016: -$3.2M → -$55.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$55.9M | -110.5% |
| FY2024 | -$26.6M | +29.4% |
| FY2023 | -$37.6M | -93.2% |
| FY2022 | -$19.5M | -128.6% |
| FY2021 | -$8.5M | -29.9% |
| FY2020 | -$6.6M | -723.7% |
| FY2019 | $1.1M | +105.5% |
| FY2018 | -$19.2M | -520.3% |
| FY2017 | -$3.1M | +2.6% |
| FY2016 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice